Johnson Johnson

Johnson Johnson together with its subsidiaries researches and develops manufactures and sells various products in the healthcare field worldwide but strategically separated its Consumer Health business into Kenvue Inc in 2023 to focus on its highergrowth innovationdriven segments the former Consumer Health brands including TYLENOL LISTERINE and BANDAID are now owned by Kenvue The companys core focus is now split between its Innovative Medicine formerly Pharmaceutical segment which offers prescription products for complex diseases such as rheumatoid arthritis various cancers HIVAIDS and neurodegenerative disorders and its MedTech Medical Devices segment which provides advanced technology solutions including electrophysiology products neurovascular care products orthopaedics hips knees spine advanced surgery solutions and disposable contact lenses under the ACUVUE brand Companys two remaining segments primarily serve hospitals healthcare professionals wholesalers and retailers continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick New Jersey